eyesON | R&D Efficiency: Big Pharma Overview
Explore the R&D efficiency and it's return on investment of the biggest publicly traded pharma companies.
Explore the R&D efficiency and it's return on investment of the biggest publicly traded pharma companies.
In this blog post, Keith Dorricott, our lead instructor at MyRBQM Academy, takes us on a reflective journey through the mindsON RBQM series. From its inception to its evolution and impact on over 1000 participants across 150 companies, Keith shares his insights and experiences.
Explore the impact of ICH's Q9(R1), Quality Risk Management, guideline on RBQM and clinical trials in our latest blog post. Don't miss our free infographic that simplifies this complex guideline. Enhance your risk strategies today!
Our MyRBQM Functional Service Provision model redefines FSP models in clinical trials with its unique, independent RBQM solutions. It offers integrated risk management strategies, AI-augmented tools like the MyRBQM Portal, and specialized training through the MyRBQM Academy, setting new industry standards.
We proudly present our virtual dialogue on Responsible AI in Clinical Trials this November 15 & 16, uniting industry and academic experts for groundbreaking discussions and insights.
Happymeter: Decoding Happiness - we measured what makes us happy! Explore global joy and key happiness contributors using data insights.
Explore the intricate balance between economy and well-being. Discover how country's GDP and health expenditure influence core health outcomes.
In a fast-changing pharma landscape, our MyRBQM® Portal transforms clinical trial and pipeline oversight and aids in M&A due diligence, offering a strategic edge in compliance and growth.
Explore how Vanguard companies, innovative small pharma entities, differ in research focus and recruitment dynamics from larger Pharma.
Phase II Vanguards data visualization tool provides oversight of groundbreaking investigational new drugs and under-the-radar institutions developing them.